933690-44-9 Usage
Uses
Used in Medical Treatments:
2-Azabicyclo[2.2.1]heptane-2-acetic acid is used as a local anesthetic and analgesic for its ability to block nerve conduction and provide pain relief. Its potential use in medical treatments is due to its ability to block the reuptake of neurotransmitters such as dopamine, serotonin, and norepinephrine in the brain, which may contribute to its therapeutic effects.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-Azabicyclo[2.2.1]heptane-2-acetic acid is used as a research compound for the development of new drugs with potential applications in pain management and other medical conditions. Its structural relationship to cocaine and atropine provides a basis for exploring its potential therapeutic properties and understanding its mechanism of action.
However, it is important to note that the use of 2-Azabicyclo[2.2.1]heptane-2-acetic acid is limited due to its similar psychoactive properties to cocaine and potential for abuse. As a result, it is classified as a controlled substance in some countries, and further research is needed to fully understand its potential benefits and risks before it can be widely adopted in medical treatments and pharmaceutical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 933690-44-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,3,6,9 and 0 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 933690-44:
(8*9)+(7*3)+(6*3)+(5*6)+(4*9)+(3*0)+(2*4)+(1*4)=189
189 % 10 = 9
So 933690-44-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H13NO2/c10-8(11)5-9-4-6-1-2-7(9)3-6/h6-7H,1-5H2,(H,10,11)
933690-44-9Relevant academic research and scientific papers
2, 4, 6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOSITOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER
-
Page/Page column 92, (2010/02/15)
The invention concerns pyrimidine derivatives of Formula (I) wherein each of p, R1, R2, q, R3, r, R4, X1 and Q1 have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the production of an anti-proliferative effect in a warm-blooded animal such as man.
